|
|
||||||||
and IL-10 to Shigella Invasins by Mononuclear Cells from Volunteers Orally Inoculated with a Shiga Toxin-Deleted Shigella dysenteriae Type 1 Strain1


*
Center for Vaccine Development, Departments of Pediatrics and Medicine, University of Maryland School of Medicine, Baltimore, MD 21201;
Department of Biology, St. Louis University, St. Louis, MO 63103; and
Unité de Pathogénie Microbienne Moléculaire, Unité 389, Institut Nationale de la Santé et de la Recherche Médicale, Institut Pasteur, Paris, France
Volunteers were orally administered invasive, non-Shiga
toxin-producing Shigella dysenteriae 1 to establish a
challenge model to assess vaccine efficacy. In stepwise fashion, four
separate groups were given 3 x 102, 7 x
103, 5 x 104, or 7 x
105 CFU. Using PBMC, proliferative responses and cytokine
production were measured to S. dysenteriae whole-cell
preparations and to purified recombinant invasion plasmid Ags (Ipa) C
and IpaD. Anti-LPS and anti-Ipa Abs and Ab-secreting cells were
also evaluated. Preinoculation PBMC produced considerable quantities of
IL-10 and IFN-
, probably secreted by monocytes and NK cells,
respectively, of the innate immune system. Following inoculation, PBMC
from 95 and 87% of volunteers exhibited an increased production of
IFN-
and IL-10, respectively, in response to Shigella
Ags. These increases included responses to IpaC and IpaD among those
volunteers receiving the lowest inoculum. No IL-4 or IL-5 responses
were detected. Whereas there were no Ab or Ab-secreting cell responses
in volunteers receiving the lowest inoculum, other dose groups had
moderate to strong anti-LPS and anti-Ipa responses. These
results suggest that in humans, type 1 responses play an important role
in mucosal and systemic immunity to S. dysentariae
1.
This article has been cited by other articles:
![]() |
K. L. Kotloff, D. N. Taylor, M. B. Sztein, S. S. Wasserman, G. A. Losonsky, J. P. Nataro, M. Venkatesan, A. Hartman, W. D. Picking, D. E. Katz, et al. Phase I Evaluation of {Delta}virG Shigella sonnei Live, Attenuated, Oral Vaccine Strain WRSS1 in Healthy Adults Infect. Immun., April 1, 2002; 70(4): 2016 - 2021. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Bernardini, J. Arondel, I. Martini, A. Aidara, and P. J. Sansonetti Parameters Underlying Successful Protection with Live Attenuated Mutants in Experimental Shigellosis Infect. Immun., February 1, 2001; 69(2): 1072 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Turbyfill, A. B. Hartman, and E. V. Oaks Isolation and Characterization of a Shigella flexneri Invasin Complex Subunit Vaccine Infect. Immun., December 1, 2000; 68(12): 6624 - 6632. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |